1-3 of 3
Barry K Moser, PhD
Close
Sort by
Journal Articles

Challenges for Conducting Clinical Trials Evaluating Maintenance Chemotherapy In Acute Myeloid Leukemia (AML): a Cancer and Leukemia Group B (CALGB) Study

William Blum, MD, Kate Donohue, PhD, Guido Marcucci, MD, Daniel J DeAngelo, MD, PhD, Geoffrey L Uy, MD, Bayard L Powell, MD, Wendy Stock, MD, Maria Baer, MD, Jonathan E Kolitz, MD, Meir Wetzler, MD, Eva Hoke, Barry K Moser, PhD, Richard A Larson, MD
Journal: Blood
Blood (2010) 116 (21): 2176.
https://doi.org/10.1182/blood.V116.21.2176.2176
Published: 2010
Journal Articles

Clonal Markers In Relapsed Acute Promyelocytic Leukemia (APL): Clinicopathological Associations and Relation to All-Trans Retinoic Acid (ATRA) Treatment on Intergroup Phase III Trial C9710.

Robert E. Gallagher, MD, Barry K. Moser, PhD, Janis Racevskis, Xavier Poiré, MD, Clara D. Bloomfield, MD, Andrew J. Carroll, PhD, Rhett Ketterling, Diane Ralston, Esther Schachter-Tokarz, Dacheng Zhou, MD, PhD, I-Ming L. Chen, DVM, MS, Richard Harvey, Greg Koval, MS, Dorie A Sher, BS, James H. Feusner, MD, Martin S. Tallman, MD, Frederick R. Appelbaum, MD, Richard A. Larson, MD, Bayard L. Powell, MD, Elisabeth Paietta, PhD, Cheryl L. Willman, MD, Wendy Stock, MD
Journal: Blood
Blood (2010) 116 (21): 1038.
https://doi.org/10.1182/blood.V116.21.1038.1038
Published: 2010
Journal Articles

FLT3 Mutations Are Prevalent and Are Significantly Associated with Induction Death In Pediatric Acute Promyelocytic Leukemia, a Report From the Children's Oncology Group

Matthew A. Kutny, MD, Barry K. Moser, PhD, John Gregory, MD, William G. Woods, MD, James H. Feusner, MD, Soheil Meshinchi, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 753.
https://doi.org/10.1182/blood.V116.21.753.753
Published: 2010